DuPont and Epicore Biosystems Collaborate to Advance Worker Safety Through Smart Wearable Technology
Rising temperatures and extreme climate conditions contribute to cognitive and physical decline, particularly in physically demanding industries. A 2024 Department of Labor Occupational Safety and Health (OSHA) Notice of Proposed Rulemaking (NPRM) for Heat Injury and Illness Prevention in Outdoor and Indoor Work Settings underscores the growing regulatory attention in this area. As a result, personalized hydration and physiologically driven safety measures are critical to mitigate the risks of heat exhaustion and stress. Epicore's Connected Hydration wearable solution1 provides real-time hydration and physiological tracking. In combination with DuPont's personal protective clothing, these biometric data streams and personalized recommendations have the potential to offer unparalleled insights about worker safety under various work conditions.
"We are thrilled to collaborate with DuPont to unlock new worker safety applications for our Connected Hydration platform," said Matt Marrapode, Vice President of Strategy at Epicore Biosystems. "Our overarching goal is to empower workers with personalized hydration insights, enabling them to perform at their best while minimizing risks associated with dehydration and heat exposure. This collaboration with DuPont represents an important step toward combining wearable hydration management solutions with personal protective equipment."
Epicore's Connected Hydration platform1 is the first smart wearable solution in the market that helps workers proactively manage their hydration and recovery using sweat-sensing technology. Connected Hydration has been broadly deployed across North America, Asia, Australia, and the Middle East in sports, wellness, and industrial settings. By integrating Epicore's data-driven health monitoring solutions with DuPont's portfolio of personal protective clothing, the companies are uniquely positioned to explore new individualized strategies to support workers in high-risk environments requiring protective gear.
"Our mission at DuPont is to protect workers and to help ensure their well-being in the workplace. Collaborating with Epicore Biosystems enables our team to explore advanced biometrics in tandem with our industry-leading personal protective solutions," said Liz Briggs, Global Marketing Manager at DuPont.
The collaboration reflects DuPont and Epicore's shared commitment to advancing breakthrough innovations that address workers' hydration and safety needs. Both companies are helping to set the stage for a future whereby smart wearable technologies and personal protective equipment play a crucial and integrated role in the workplace.
To learn more about Epicore Biosystems and its suite of wearable technology, visit www.epicorebiosystems.com. For more on DuPont Personal Protection, visit https://www.dupont.com/personal-protection/tyvek-for-ppe.html.
About Epicore Biosystems:
Epicore Biosystems is a digital health company spun out of Northwestern University's Querrey Simpson Institute for Bioelectronics and the John Rogers Laboratory. Epicore has developed advanced sweat-sensing wearables that provide real-time personalized health insights. Their clinically validated biowearable solutions and cloud analytics are deployed globally and licensed by leading Fortune 500 companies, the Department of Defense and the National Institute of Health. To learn more, visit: https://www.epicorebiosystems.com/. Follow Epicore on LinkedIn.
1 https://www.epicorebiosystems.com/our-solutions/connected-hydration
About DuPont:
DuPont (NYSE: DD) is a global innovation leader with technology-based materials and solutions that help transform industries and everyday life. Our employees apply diverse science and expertise to help customers advance their best ideas and deliver essential innovations in key markets including electronics, transportation, construction, water, healthcare and worker safety. More information about the company, its businesses and solutions can be found at www.dupont.com/. Investors can access information included on the Investor Relations section of the website at investors.dupont.com.
This information is based upon technical data that DuPont believes to be reliable. It is subject to revision as additional knowledge and experience become available. It is the user's responsibility to determine the level of toxicity and the proper personal protective equipment needed. The information set forth herein reflects laboratory performance of fabrics, not complete garments, under controlled conditions. This information is intended for use by persons having the technical expertise to undertake evaluation under their own specific end-use conditions, at their own discretion and risk. Anyone intending to use this information should first check that the garment selected is suitable for the intended use. The end-user should discontinue use of garment if fabric becomes torn, worn or punctured, to avoid potential chemical exposure. Since conditions of use are beyond our control, DUPONT DE NEMOURS AND ITS AFFILIATES MAKE NO WARRANTIES, EXPRESSED OR IMPLIED, INCLUDING BUT NOT LIMITED TO WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE AND ASSUME NO LIABILITY IN CONNECTION WITH ANY USE OF THIS PRODUCT OR INFORMATION. This information is not intended as a license to operate under or a recommendation to infringe any trademark, patent or technical information of DuPont or other persons covering any material or its use.
© 2025 DuPont. All rights reserved. DuPont™, the DuPont Oval Logo, and all trademarks and service marks denoted with ™, ℠ or ® are owned by affiliates of DuPont de Nemours, Inc. unless otherwise noted.
05/2025
View original content to download multimedia:https://www.prnewswire.com/news-releases/dupont-and-epicore-biosystems-collaborate-to-advance-worker-safety-through-smart-wearable-technology-302460794.html
SOURCE Epicore Biosystems, Inc.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
8 minutes ago
- Yahoo
C3 AI (AI) Nosedives as Preliminary Results ‘Completely Unacceptable'
We recently published . Inc. (NYSE:AI) is one of the best-performing stocks on Monday. fell for a fourth straight day on Monday, slashing 25.58 percent to close at $16.47 apiece after its chief executive called the preliminary results of its first quarter of fiscal year 2026 performance 'completely unacceptable.' According to Inc. (NYSE:AI), it was targeting to report total revenues of $70.2 million to $70.4 million, and GAAP operational loss of $124.7 million to $124.9 million. Non-GAAP loss from operations was targeted at $57.7 million to $57.9 million. Commenting on the results, Inc. (NYSE:AI) CEO Tom Siebel said the sales figures were 'completely unacceptable,' and pointed to disruptions from a recent leadership reorganization, and his health contributing to the company's poor performance. Last month, Inc. (NYSE:AI) announced that it was searching for a new CEO after Siebel tendered his resignation due to health reasons, effective upon a successor assuming his post. 'After being diagnosed with an autoimmune disease in early 2025, I have experienced significant visual impairment,' he was quoted as saying last month. 'For C3 AI to reach its full potential—which I believe is spectacular—the board and I have initiated a search for a new CEO who can take the company to the next level of growth and success. I will remain fully engaged as Chief Executive Officer of until such time as the board appoints my successor, after which I will continue in the role of Executive Chairman, focusing on strategy, product innovation, strategic partner and customer relationships,' he noted. While we acknowledge the potential of AI as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the .
Yahoo
39 minutes ago
- Yahoo
DigitalOcean (DOCN) Loses 10.56% on $500-Million Notes Issuances
We recently published . DigitalOcean Holdings, Inc. (NYSE:DOCN) is one of the best-performing stocks on Monday. DigitalOcean fell for a third straight day on Monday, losing 10.56 percent to close at $29.56 apiece following plans to raise $500 million from the issuance of convertible senior notes due 2030. In a statement, DigitalOcean Holdings, Inc. (NYSE:DOCN) said the notes will be senior, unsecured obligations, will accrue interest payable semi-annually in arrears, and will mature on August 15, 2030, unless earlier converted, redeemed or repurchased. However, the notes will not be redeemable before August 15, 2028. Noteholders will have the right to convert their notes to cash, its common shares, or a combination of both. DigitalOcean Holdings, Inc. (NYSE:DOCN) also granted its initial buyers the option to purchase up to an additional $75 million within 13 days from the issuance date of the notes. DigitalOcean Holdings, Inc. (NYSE:DOCN) said it plans to use the proceeds to pay the cost of the transaction, and the remainder to repurchase for cash a portion of its convertible senior notes due 2026. The balance, if any, will be allocated for general corporate purposes. While we acknowledge the potential of DOCN as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the .
Yahoo
39 minutes ago
- Yahoo
Clearwater Analytics (CWAN) Falls 6.44% on Dismal Earnings
We recently published . Clearwater Analytics Holdings, Inc. (NYSE:CWAN) is one of the best-performing stocks on Monday. Clearwater Analytics saw its share prices decline by 6.44 percent on Monday to end at $18.45 apiece as investor sentiment remains dampened by a dismal earnings performance in the second quarter of the year, despite earning a rating upgrade from an investment company. In an updated report, Clearwater Analytics Holdings, Inc. (NYSE:CWAN) widened its net loss attributable to shareholders in the second quarter of the year by 5,301 percent to $23.2 million from only $430,000 in the same period last year. Revenues were higher by 70 percent to $181.9 million from $106.79 million year-on-year. The company also swung to a net loss of $16.5 million in the first half of the year from a net income of $1.47 million in the same comparable period. Revenues grew by 47 percent to $308.8 million from $209.5 million year-on-year. A man in long sleeves looking at stock market data. Photo by Tima Miroshnichenko on Pexels Despite the results, Clearwater Analytics Holdings, Inc. (NYSE:CWAN) earned a 'buy' recommendation from Goldman Sachs, a revision from the 'neutral' stance previously. However, it maintained its price target of $27 for the stock. While we acknowledge the potential of CWAN as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the . Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
